LifeMine Therapeutics Inc.
eDR50Effective DR: 50/100. Below median. Measured by StartupHub.ai. Median 68.Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
About
LifeMine Therapeutics is a clinical-stage biopharmaceutical company pioneering "Top-Down Drug Discovery™" by leveraging evolutionary insights from fungi to unearth next-generation precision medicines. Their data-immersive and technologically expansive discovery engine aims to bring sophisticated medicines to patients in urgent need of breakthrough disease intervention. The company's lead clinical-stage program, LIFE-001, is a novel calcineurin activation inhibitor being developed for the prevention of organ transplant rejection.
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Biotech
Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
Shares Biotechnology, Drug Discovery
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Genomics
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Therapeutics
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Drug Discovery
Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.
Shares Biotechnology, Drug Discovery
Key facts
- Website
- lifeminetx.com
- Headquarters
- Watertown, United States
- Founded
- 2017
- Employees
- 31
- Total funding
- $543M (Funding Round)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 5 Aug 2026 | Funding Round | $263M | |
| 1 Mar 2022 | Series C | $175M | Fidelity Management & Research Company |
| 7 Jan 2021 | Series B | $50M | Milky Way Cap, Richard Klausner (Angel Investor) |
| 15 Sept 2017 | Series A | $55M |
Tech stack
Detected on lifeminetx.com, last scanned 30 Oct 2026. Run your own scan
- Frontend
- Tailwind CSS
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Mimecast
- DevOps
- Atlassian
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
What is LifeMine Therapeutics Inc.'s Effective Domain Rating?
StartupHub's Effective Domain Rating for LifeMine Therapeutics Inc. is 50 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 33, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.
Is LifeMine Therapeutics Inc. trustworthy and reputable?
StartupHub's Data Trust & Reputation score for LifeMine Therapeutics Inc. is 75 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has LifeMine Therapeutics Inc. raised?
LifeMine Therapeutics Inc. has raised a total of $543M in funding. The most recent round on record is Funding Round.
How many employees does LifeMine Therapeutics Inc. have?
LifeMine Therapeutics Inc. has approximately 31 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for LifeMine Therapeutics Inc.:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
